Avtos Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.84%
- Profit Growth 40.54%
- Ebitda 37.26%
- Net Worth -16.73%
- Total Assets -0.24%
About Avtos Life Sciences
Avtos Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 2011 and has a history of 13 years and two months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Vtos Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Kabbin, Mukund Gadre, Ranjan Mogre, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232MH2011PTC224404
- Company No.
224404
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Avtos Life Sciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Kabbin  | Director | 25-Nov-2011 | Current |
| Aniruddha Vaidya | Director | 24-Sep-2012 | Current |
| Mukund Gadre | Director | 25-Nov-2011 | Current |
| Ranjan Mogre | Director | 24-Sep-2012 | Current |
| Vijayanand Bhate | Director | 24-Sep-2012 | Current |
Financial Performance of Avtos Life Sciences.
Avtos Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 43.84% increase. The company also saw a substantial improvement in profitability, with a 40.54% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avtos Life Sciences?
In 2018, Avtos Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indtech Instruments Private LimitedNitin Kabbin and Mukund Gadre are mutual person
Biogenomics LimitedRanjan Mogre and Vijayanand Bhate are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avtos Life Sciences?
Unlock and access historical data on people associated with Avtos Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avtos Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avtos Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.